Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal basal ganglia morphology (HP:0002134)help
Parent Node:
expand
Abnormal corpus striatum morphology (HP:0010994)help
..Starting node
..expand
Abnormal caudate nucleus morphology (HP:0002339)help
Term ID: 2339
Name: Abnormal caudate nucleus morphology
Synonym: Abnormality of the caudate nucleus
Definition: Any structural abnormality of the caudate nucleus.
Comments:
Reference: HP:0002339
Genes and Diseases:
 
       Child Nodes:
........expandAtrophy/Degeneration involving the caudate nucleus (HP:0007374) help
................... HP:0002340 Caudate atrophy
........expandIncreased caudate lactate level (HP:0012644) help

 Sister Nodes: 
..expandDegeneration of the striatum (HP:0040140) help
..expandStriatal T2 hyperintensity (HP:0031206) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002339HP:0002339Abnormal caudate nucleus morphology0ADAR CL E G H103225ORPHA:225154Familial infantile bilateral striatal necrosis116
HP:0002339HP:0002339Abnormal caudate nucleus morphology0ATP13A2 CL E G H2340030213ORPHA:314632ATP13A2-related juvenile neuronal ceroid lipofuscinosisHP:0040283 - Occasional100
HP:0002339HP:0002339Abnormal caudate nucleus morphology0ATP6 CL E G H45087414ORPHA:225154Familial infantile bilateral striatal necrosis
HP:0002339HP:0002339Abnormal caudate nucleus morphology0BSCL2 CL E G H2658015832ORPHA:363400Severe neurodegenerative syndrome with lipodystrophy105
HP:0002339HP:0002339Abnormal caudate nucleus morphology0COASY CL E G H8034729932ORPHA:397725COASY protein-associated neurodegenerationHP:0040281 - Very frequent16
HP:0002339HP:0002339Abnormal caudate nucleus morphology0DCX CL E G H16412714ORPHA:2148Lissencephaly type 1 due to doublecortin gene mutationHP:0040283 - Occasional145
HP:0002339HP:0002339Abnormal caudate nucleus morphology0FOXP2 CL E G H9398613875ORPHA:209908Childhood apraxia of speechHP:0040283 - Occasional143
HP:0002339HP:0002339Abnormal caudate nucleus morphology0FTL CL E G H25123999ORPHA:157846NeuroferritinopathyHP:0040282 - Frequent33
HP:0002339HP:0002339Abnormal caudate nucleus morphology0GCDH CL E G H26394189ORPHA:25Glutaryl-CoA dehydrogenase deficiencyHP:0040282 - Frequent115
HP:0002339HP:0002339Abnormal caudate nucleus morphology0HTT CL E G H30644851ORPHA:399Huntington disease12
HP:0002339HP:0002339Abnormal caudate nucleus morphology0HTT CL E G H30644851OMIM:617435Lopes-Maciel-Rodan syndrome12
HP:0002339HP:0002339Abnormal caudate nucleus morphology0JPH3 CL E G H5733814203ORPHA:98934Huntington disease-like 22
HP:0002339HP:0002339Abnormal caudate nucleus morphology0NDUFAF3 CL E G H2591529918ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040283 - Occasional31
HP:0002339HP:0002339Abnormal caudate nucleus morphology0NDUFAF5 CL E G H7913315899OMIM:618238Mitochondrial complex I deficiency, nuclear type 1634
HP:0002339HP:0002339Abnormal caudate nucleus morphology0NDUFB8 CL E G H47147703ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040283 - Occasional
HP:0002339HP:0002339Abnormal caudate nucleus morphology0NDUFS2 CL E G H47207708ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040283 - Occasional65
HP:0002339HP:0002339Abnormal caudate nucleus morphology0NEK1 CL E G H47507744OMIM:617892Amyotrophic lateral sclerosis, susceptibility to, 24101
HP:0002339HP:0002339Abnormal caudate nucleus morphology0NUP62 CL E G H236368066ORPHA:225154Familial infantile bilateral striatal necrosis7
HP:0002339HP:0002339Abnormal caudate nucleus morphology0OPHN1 CL E G H49838148ORPHA:137831X-linked intellectual disability-cerebellar hypoplasia syndrome55
HP:0002339HP:0002339Abnormal caudate nucleus morphology0SCO2 CL E G H999710604ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040283 - Occasional40
HP:0002339HP:0002339Abnormal caudate nucleus morphology0SLC2A3 CL E G H651511007ORPHA:399Huntington disease1
HP:0002339HP:0002339Abnormal caudate nucleus morphology0SURF1 CL E G H683411474ORPHA:70474Leigh syndrome with cardiomyopathyHP:0040283 - Occasional73
HP:0002339HP:0002339Abnormal caudate nucleus morphology0TIMM8A CL E G H167811817ORPHA:52368Mohr-Tranebjaerg syndrome15
HP:0002339HP:0002339Abnormal caudate nucleus morphology0TREM2 CL E G H5420917761OMIM:618193POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2; PLOSL231
HP:0002339HP:0002339Abnormal caudate nucleus morphology0TUBB2B CL E G H34773330829ORPHA:300573Polymicrogyria due to TUBB2B mutationHP:0040283 - Occasional39
HP:0002339HP:0002339Abnormal caudate nucleus morphology0TUBB3 CL E G H1038120772OMIM:614039Cortical dysplasia, complex, with other brain malformations 164
HP:0002339HP:0002339Abnormal caudate nucleus morphology0TYROBP CL E G H730512449OMIM:221770Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy22
HP:0002339HP:0002339Abnormal caudate nucleus morphology0VPS13A CL E G H232301908OMIM:200150CHOREOACANTHOCYTOSIS130
HP:0002339HP:0002339Abnormal caudate nucleus morphology0VPS13A CL E G H232301908ORPHA:2388Choreoacanthocytosis130
HP:0002339HP:0012644Increased caudate lactate level1 CL E G H
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1ADAR CL E G H103225ORPHA:225154Familial infantile bilateral striatal necrosisHP:0040282 - Frequent116
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1ATP6 CL E G H45087414ORPHA:225154Familial infantile bilateral striatal necrosisHP:0040282 - Frequent
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1BSCL2 CL E G H2658015832ORPHA:363400Severe neurodegenerative syndrome with lipodystrophy105
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1FOXP2 CL E G H9398613875ORPHA:209908Childhood apraxia of speech143
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1FTL CL E G H25123999ORPHA:157846Neuroferritinopathy33
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1HTT CL E G H30644851ORPHA:399Huntington disease12
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1HTT CL E G H30644851OMIM:617435Lopes-Maciel-Rodan syndrome12
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1JPH3 CL E G H5733814203ORPHA:98934Huntington disease-like 22
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1NDUFAF5 CL E G H7913315899OMIM:618238Mitochondrial complex I deficiency, nuclear type 1634
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1NEK1 CL E G H47507744OMIM:617892Amyotrophic lateral sclerosis, susceptibility to, 24101
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1NUP62 CL E G H236368066ORPHA:225154Familial infantile bilateral striatal necrosisHP:0040282 - Frequent7
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1OPHN1 CL E G H49838148ORPHA:137831X-linked intellectual disability-cerebellar hypoplasia syndrome55
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1SLC2A3 CL E G H651511007ORPHA:399Huntington disease1
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1TIMM8A CL E G H167811817ORPHA:52368Mohr-Tranebjaerg syndrome15
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1TREM2 CL E G H5420917761OMIM:618193POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2; PLOSL231
HP:0002339HP:0034180Fusion of the caudate and putamen1TUBB3 CL E G H1038120772OMIM:614039Cortical dysplasia, complex, with other brain malformations 164
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1TYROBP CL E G H730512449OMIM:221770Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy22
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1VPS13A CL E G H232301908OMIM:200150CHOREOACANTHOCYTOSIS130
HP:0002339HP:0007374Atrophy/Degeneration involving the caudate nucleus1VPS13A CL E G H232301908ORPHA:2388Choreoacanthocytosis130
HP:0002339HP:0002340Caudate atrophy2BSCL2 CL E G H2658015832ORPHA:363400Severe neurodegenerative syndrome with lipodystrophyHP:0040283 - Occasional105
HP:0002339HP:0002340Caudate atrophy2FOXP2 CL E G H9398613875ORPHA:209908Childhood apraxia of speechHP:0040283 - Occasional143
HP:0002339HP:0002340Caudate atrophy2FTL CL E G H25123999ORPHA:157846NeuroferritinopathyHP:0040283 - Occasional33
HP:0002339HP:0002340Caudate atrophy2HTT CL E G H30644851ORPHA:399Huntington diseaseHP:0040283 - Occasional12
HP:0002339HP:0002340Caudate atrophy2HTT CL E G H30644851OMIM:617435Lopes-Maciel-Rodan syndromeHP:0040284 - Very rare12
HP:0002339HP:0002340Caudate atrophy2JPH3 CL E G H5733814203ORPHA:98934Huntington disease-like 2HP:0040283 - Occasional2
HP:0002339HP:0002340Caudate atrophy2NDUFAF5 CL E G H7913315899OMIM:618238Mitochondrial complex I deficiency, nuclear type 1634
HP:0002339HP:0002340Caudate atrophy2NEK1 CL E G H47507744OMIM:617892Amyotrophic lateral sclerosis, susceptibility to, 24101
HP:0002339HP:0002340Caudate atrophy2OPHN1 CL E G H49838148ORPHA:137831X-linked intellectual disability-cerebellar hypoplasia syndromeHP:0040283 - Occasional55
HP:0002339HP:0002340Caudate atrophy2SLC2A3 CL E G H651511007ORPHA:399Huntington diseaseHP:0040283 - Occasional1
HP:0002339HP:0002340Caudate atrophy2TIMM8A CL E G H167811817ORPHA:52368Mohr-Tranebjaerg syndromeHP:0040283 - Occasional15
HP:0002339HP:0002340Caudate atrophy2TREM2 CL E G H5420917761OMIM:618193POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY 2; PLOSL231
HP:0002339HP:0002340Caudate atrophy2TYROBP CL E G H730512449OMIM:221770Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy.22
HP:0002339HP:0002340Caudate atrophy2VPS13A CL E G H232301908OMIM:200150CHOREOACANTHOCYTOSIS.130
HP:0002339HP:0002340Caudate atrophy2VPS13A CL E G H232301908ORPHA:2388ChoreoacanthocytosisHP:0040282 - Frequent130


Genes (27) :ADAR ATP13A2 ATP6 BSCL2 COASY DCX FOXP2 FTL GCDH HTT JPH3 NDUFAF3 NDUFAF5 NDUFB8 NDUFS2 NEK1 NUP62 OPHN1 SCO2 SLC2A3 SURF1 TIMM8A TREM2 TUBB2B TUBB3 TYROBP VPS13A

Diseases (22) :ORPHA:225154 ORPHA:314632 ORPHA:363400 ORPHA:397725 ORPHA:2148 ORPHA:209908 ORPHA:157846 ORPHA:25 ORPHA:399 OMIM:617435 ORPHA:98934 ORPHA:70474 OMIM:618238 OMIM:617892 ORPHA:137831 ORPHA:52368 OMIM:618193 ORPHA:300573 OMIM:614039 OMIM:221770 OMIM:200150 ORPHA:2388
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.